原料词典检索/butyrospermum-parkii-butter/BUTYROSPERMUM PARKII BUTTER
Tier 1 Monograph · SSOT 15 FieldsRaw .md (GEO) ↗
植物提取 (Plant)

BUTYROSPERMUM PARKII BUTTER

中国 NMPA《已使用化妆品原料目录 (IECIC)》: 未列入目录 (严禁自行机器翻译标示)
皮肤调理剂粘度调节剂
[EU CosIng Official Definition] Butyrospermum Parkii Butter is the fat obtained from the fruit of the Shea Tree, Butyrospernum parkii, Sapotaceae
核心法规与安全结论 (Executive Fact Box)AEO / GEO CITATION ANCHOR

化妆品中 BUTYROSPERMUM PARKII BUTTER 的全球法规限值与配方应用标准是什么?

BUTYROSPERMUM PARKII BUTTER(CAS 号: 194043-92-0,未列入中国 IECIC 目录)是化妆品配方中主要用作皮肤调理剂, 粘度调节剂的核心成分。受中国 NMPA(未列管)、韩国 MFDS(未列管)及欧盟 CosIng(未列管)等 6 大法域法定标准监管,常规建议添加量为 1–23%(最佳稳定窗口 pH 4–8)。

全球 7 轨官方全成分标签名称对照表

严格采用各国政府官方目录原名 · 严禁机器翻译
7-Track Official Statutory Label Names for BUTYROSPERMUM PARKII BUTTER
法域与监管轨道官方公告全成分标准名称一键复制
① 韩国 (MFDS 化妆品标准名称)BUTYROSPERMUM PARKII BUTTER (KR MFDS Registered)
② 韩国旧名称历史 (301 重定向)——
③ 欧盟 (EU CosIng EC 1223/2009)BUTYROSPERMUM PARKII BUTTER
④ 美国普通化妆品 (US PCPC / MoCRA INCI)BUTYROSPERMUM PARKII (SHEA) BUTTER
⑤ 美国 OTC 防晒/祛痘专论活性物名称 (FDA OTC)— (非美国 OTC 专论活性成分 / 普通化妆品原料)—
⑥ 中国 (NMPA《已使用化妆品原料目录 IECIC》标准中文名)未列入《已使用化妆品原料目录 (IECIC)》(严禁自行翻译标示)—
⑦ 日本普通化妆品 / 医药部外品 (JCIA / MHLW)BUTYROSPERMUM PARKII BUTTER (标准 INCI 参照)

Layer 1 — 全球 6 大法域法定限值与监管状态

Layer 1 Statutory Regulatory Limits Across 6 Regions for BUTYROSPERMUM PARKII BUTTER
法域监管状态法定限值适用条件与法定依据来源
韩国 (MFDS)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
欧盟 (EU)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
美国 (FDA)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
中国 (NMPA)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
日本 (MHLW)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
东盟 (ACD)未列管GMP已列入官方化妆品原料目录 (按 GMP 规范使用)
⚠️ 仅供参考 (免责声明): 本词典中的原料名称、法规限值与配比指南仅供研发参考。鉴于法规修订时差或潜在数据误差,实际配方设计、标签印制及备案前请务必核实主管部门最新官方公告原文;因使用本词典信息产生的任何问题,运营方概不承担法律责任。
Interactive Quartile Box-Plot (Min–Q1–Median–Q3–Max)

Layer 3 Formulation Concentration Box-Plot vs. Statutory Limit

Anhydrous Balm / Oiln=5
Min 1% · Q1 2% · Median 5% · Q3 10% · Max 23%
Rinse-off Cleansern=5
Min 3% · Q1 3% · Median 5% · Q3 11.5% · Max 11.5%
Emulsion / Creamn=6
Min 1% · Q1 1% · Median 1% · Q3 1.75% · Max 9.8%
Anhydrous Balm / Oil — Anhydrous balm, oil & stick structural emollient
Verified Source: Global Starter Formulation Library Statistical Distribution (n=5, SEPPIC 3 · EVONIK 2) (cir_safety) · SEPPIC 3 · EVONIK 2
Typical Median: 5%

Layer 3 — 剂型常规配比指南与理化配伍性

Layer 3 Formulation Concentration Quartiles by Product Category for BUTYROSPERMUM PARKII BUTTER
剂型分类Min – Q1 – Median – Q3 – Max (%)配方作用与机理Source ID
剂型组 E — 无水精油 / 固体膏霜 / 唇部护理1% · 2% · 5% · 10% · 23%Anhydrous balm, oil & stick structural emollientGlobal Starter Formulation Library Statistical Distribution (n=5, SEPPIC 3 · EVONIK 2)
剂型组 C — 淋洗类洁面 / 洗发水 / 沐浴露3% · 3% · 5% · 11.5% · 11.5%Rinse-off cleanser & surfactant system modifierGlobal Starter Formulation Library Statistical Distribution (n=5, EVONIK 5)
剂型组 B — 乳液 / 面霜 (O/W · W/O)1% · 1% · 1% · 1.75% · 9.8%Emulsion cream & lotion structural / conditioning agentGlobal Starter Formulation Library Statistical Distribution (n=6, EVONIK 2 · GRANT 2 · SEPPIC 2)
Cutaneous Permeation Science (500 Dalton Rule)MW: Macro/Complex · LogP: N/A

Stratum Corneum Penetration Depth & Bio-Spicule Transdermal Delivery

Stratum Corneum (Brick & Mortar Barrier · 10–20 µm)500 Da Molecular Weight Cutoff BarrierViable Epidermis (Keratinocytes & Melanocytes · 50–100 µm)Target for Brightening (Tyrosinase/Melanosome) & Barrier LipidsPapillary Dermis (Fibroblasts & ECM Collagen · 150–300 µm)Target for Collagen I/III Synthesis, Peptides, PDRN & ExosomesEpidermal Passive Permeation (<500 Da)
Molecular Weight & LogP Permeation Diagnosis
Low Molecular Weight (320 Da ≤ 500 Da) — Passive Permeation Feasible

Under passive topical application, molecules diffuse tortuously through intercellular lipids. Hydrophilic compounds >500 Da remain primarily on the outer stratum corneum.

Estimated Target Depth
40–90 µm
Optimal Delivery System
Polyol Enhancer / Serum
Colloid Interface, pH Spectrum & Thermal Stability

pH Stability Window (0–14), Thermal Limit & HLB Colloidal Phase Behavior

Water or glycol phase soluble/dispersible
Optimal Formulation pH Stability Window (0–14)pH 4.0 – 8.0
0245.5791114

Outside pH 4–8, risk of hydrolysis, viscosity loss, or ionic dissociation increases.

Maximum Thermal Processing Limit (°C)≤ 50°C
25°C45°C60°C75°C85°C100°C

Thermally stable up to 50°C during standard emulsification.

HLB Scale (0–20) & Colloidal Micelle / Lamellar Phase Simulator
O/W Oil-in-Water Micelle Emulsion (Lotion / Cream)
HLB 11.5
W/O (3–6)Lamellar (8–10.5)O/W Emulsion (11–15)Solubilizer (15–19)O/W Droplet
Biochemical Signaling & Mechanism Pathway

Cellular & Molecular Target Mechanism Flow

1. Epidermal Interaction→ Upregulation / Activation
Intercellular Lipid & Hydration Matrix
→
TEWL Reduction & Barrier Conditioning
2. Homeostasis Modulation⊣ Inhibition / Blockade
Oxidative Stress (ROS) & Irritant Cascade
⊣
Cutaneous Soothing & Homeostasis
Formulation Ontology Radial Graph

Interactive Synergy Pairings (Solid) & Incompatibility Warnings (Dashed)

+ GLYCERIN+ CAPRYLIC/CAPRIC TR…+ TOCOPHEROL✕ Verify phase compati…BUTYROSPERMUM PARK…
Interactive Node Guide

Click any green synergy node to jump directly to its monograph, or click a red dashed node to inspect the chemical incompatibility mechanism.

代表性商品名参考 (商标法第90条第1款第2项说明性标示)
BUTYROSPERMUM PARKII BUTTER

商品名仅供配方师识别原料规格参考,商标权归各原厂商所有。

学术与毒理综合摘要

Tier 1 Synthesis

本综述严格基于与该原料关联的 NIH PubMed 同行评审文献摘要及官方毒理学评估档案编写。

■ [1. Chemical Identity & International Labeling Nomenclature] - INCI Name: BUTYROSPERMUM PARKII BUTTER | CAS No.: 194043-92-0 | EC No.: 293-515-7 - Origin: PLANT | Functions: Skin Conditioning, - Physicochemical Profile: Formula | MW /(Polymer/Complex) | / | Ionic Nature: non-ionic | CosIng/MFDS - Official Regional Label Names: US [BUTYROSPERMUM PARKII (SHEA) BUTTER] · EU [BUTYROSPERMUM PARKII BUTTER] · CN [-] · JP [-] · JP Quasi-Drug [-] ■ [2. Dermatological Mechanism of Action & Functional Role] - Butyrospermum Parkii Butter is the fat obtained from the fruit of the Shea Tree, Butyrospernum parkii, Sapotaceae Classified under origin 'plant', it acts within the cosmetic vehicle or stratum corneum to deliver , performance and structural formulation stability. ■ [3. Global 6-Jurisdiction Regulatory Status & Safety Limits (Layer 1 & Layer 2)] - Regional Summary: KR: NONE | EU: NONE | US: NONE | CN: NONE | JP: NONE | ASEAN: NONE (CN IECIC (2025) Entry No. Unlisted (-)) - No specific Annex prohibition or numeric restriction across the 6 major jurisdictions (Permitted under general GMP safety assessment). - Official Safety & Historical Use Concentration (Layer 2): Quantum satis (QS) within standard cosmetic safety margins ■ [4. Formulation Dosage Guide by Product Category (Layer 3-A)] - [anhydrous_balm] Typical range: 1.0 ~ 23.0% (Median 5.0%, Ref: Global Starter Formulation Library Statistical Distribution (n=5, SEPPIC 3 · EVONIK 2)) — Anhydrous balm, oil & stick structural emollient - [cleanser_rinse] Typical range: 3.0 ~ 11.5% (Median 5.0%, Ref: Global Starter Formulation Library Statistical Distribution (n=5, EVONIK 5)) — Rinse-off cleanser & surfactant system modifier - [emulsion_cream] Typical range: 1.0 ~ 9.8% (Median 1.0%, Ref: Global Starter Formulation Library Statistical Distribution (n=6, EVONIK 2 · GRANT 2 · SEPPIC 2)) — Emulsion cream & lotion structural / conditioning agent ■ [5. Formulation Engineering, Stability & Incompatibility Matrix (Layer 3-B)] - Addition Phase: Water Phase or Cool-down Phase (< 45°C) - Optimal pH Range: pH 4.0 ~ 8.0 | Max Process Temp: Max 50°C | Electrolyte Tolerance: MEDIUM - Incompatibility / Caution: Verify phase compatibility under extreme pH or high electrolyte loads - Synergy Pairings: GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL | Reference Trade Names: BUTYROSPERMUM PARKII BUTTER ■ [6. Peer-Reviewed Literature & Official Compendia Evidence] - PMID 33934478 (2021, J Cosmet Dermatol): A novel treatment of diaper dermatitis in children and adults - PMID 33934472 (2021, J Cosmet Dermatol): A novel treatment of intertrigo in athletes and overweight subjects - PMID 32385930 (2020, J Cosmet Dermatol): Butyrospermum parkii butter increased the photostability and in vivo SPF of a molded sunscreen system

关联同行评审文献 (NIH PubMed) (6)

A novel treatment of diaper dermatitis in children and adults [PMID: 33934478 · 2021]
Dall'Oglio F, Musumeci ML, Puglisi DF, Micali G · J Cosmet Dermatol (2021)

Diaper dermatitis (DD) is an acute inflammatory reaction, regardless of the cause, of the diaper-covered area. Topical skin barrier repair cosmetic products are the mainstay treatment to cure and/or prevent DD. To assess the efficacy/tolerability of a zinc gluconate-taurine/zinc oxide and panthenol/ glycerin/ Butyrospermum parkii butter barrier cream using clinical evaluation. In this prospective, open-label trial, 20 patients (10 infants/10 adults), with mild/moderate DD enrolled at the Dermatology University Clinic of Catania (Italy) were instructed to apply the cream twice daily for 30&#xa0;days. Degree of erythema was performed clinically by a 5-point severity scale (from 0&#xa0;=&#xa0;no erythema to 4&#xa0;=&#xa0;severe erythema), at baseline, at 15 and 30&#xa0;days. An Investigator Global Assessment (IGA) using a 6-point scale (from -1&#xa0;=&#xa0;worsening to 4&#xa0;=&#xa0;complete response/clear) along with product tolerability was also performed at 15 and 30&#xa0;days. Statistical analysis was performed using SAS version 9. At 15&#xa0;days, a reduction of clinical erythema assessment (CEA) from baseline was observed (mean from 3.2&#xa0;&#xb1;&#xa0;0.8 to 2.5&#xa0;&#xb1;&#xa0;0.3; p&#xa0;&lt;&#xa0;0.06), that although nonsignificant, showed a significant progressive improvement at 30&#xa0;days (mean from 3.2&#xa0;&#xb1;&#xa0;0.8 to 1.1&#xa0;&#xb1;&#xa0;0.9; p&#xa0;&lt;&#xa0;0.0001) without any age differences. Our preliminary results indicate that the tested barrier cream may represent a promising approach in DD rash. It may be used in mild-to-moderate forms in monotherapy without significant side effects or, where required, in association with pharmacological agents. Its long-term use is likely safe.

A novel treatment of intertrigo in athletes and overweight subjects [PMID: 33934472 · 2021]
Verz&#xec; AE, Nasca MR, Dall'Oglio F, Cosentino C, Micali G · J Cosmet Dermatol (2021)

Intertrigo is a recurrent inflammatory dermatosis involving large/small body folds. Skin barrier products represent the mainstay of treatment in uncomplicated mild/moderate intertrigo. To assess by clinical and instrumental evaluation the efficacy and tolerability of a new barrier spray containing zinc gluconate-taurine complex and zinc oxide combined with panthenol, glycerin, and Shea (Butyrospermum parkii) butter in mild-to-moderate intertrigo in athletes and overweight subjects. In this open-label prospective trial, 20 adult patients, with mild/moderate intertrigo enrolled at the Dermatology University Clinic of Catania (Italy), were instructed to apply the spray twice daily for 30&#xa0;days. Degree of erythema was performed clinically and by polarized dermoscopy using a 5-point severity scale (from 0=no erythema to 4=severe erythema) at baseline, and at 15 and 30&#xa0;days. The measurement of pruritus was carried out by a subject-completed visual analog scale (VAS) (from 0&#xa0;mm=no pruritus to 100&#xa0;mm=severe pruritus), at all time points. An Investigator Global Assessment (IGA) using a 6-point scale (from -1=worsening to 4=complete response/clear) was also conducted at 30&#xa0;days, along with a self-administered tolerability questionnaire. Statistical analysis was performed using SAS version 9. At 15&#xa0;days, a statically significant reduction from baseline in erythema severity (mean from 3.4&#xa0;&#xb1;&#xa0;0.3 to 2.5&#xa0;&#xb1;&#xa0;0.2) along with pruritus intensity (mean from 70&#xa0;&#xb1;&#xa0;15.4&#xa0;mm to 40&#xa0;&#xb1;&#xa0;9.5&#xa0;mm) was observed. At 30&#xa0;days, all evaluated parameters showed a further progressive statistically significant reduction from baseline. No relevant side effects were recorded. Our results suggest that the tested spay containing antiseptic/anti-inflammatory and anti-irritation agents may represent a valid therapeutic option for mild/moderate intertrigo.

Butyrospermum parkii butter increased the photostability and in vivo SPF of a molded sunscreen system [PMID: 32385930 · 2020]
Sarruf FD, Sauce R, Candido TM, Oliveira CA, Rosado C, Velasco MVR, Baby AR · J Cosmet Dermatol (2020)

Ultraviolet (UV) radiation exposure is related to skin and lip tumors. Therefore, the development of photoprotective lipstick formulations is of utmost importance. Considering the biological properties of Shea butter (Butyrospermum parkii), we assessed its potential as an adjuvant in a molded lipstick sunscreen system by in vivo tests and photostability. Shea butter was used in a photoprotective lipstick formulation at two different concentrations (10.0% and 15.0% w/w) associated with ethylhexyl methoxycinnamate (EHM) and titanium dioxide. Skin compatibility was assessed in vivo. The in vivo SPF value was determined according to the current recognized method. Additionally, the photostability of EHM was determined by high-performance liquid chromatography. By the cutaneous compatibility, the product presented no interference with skin barrier and no adverse reactions, thus proving its safety. The in vivo SPF assay showed that the highest concentration of Shea butter increased the in vivo SPF value of the sample by 35%, demonstrating it to be a booster in photoprotective lipstick formulations. Also, Shea butter was proved to enhance the photostability of EHM, a commonly used UVB filter available in several countries. Shea butter increased the photostability and in vivo SPF of a molded lipstick sunscreen.

Influence of Shea (Butyrospermum parkii) butter, TiO(2) and ethylhexyl methoxycinnamate on physical parameters and in vitro photoprotective efficacy [PMID: 31856404 · 2020]
Sarruf FD, C&#xe2;ndido TM, de Oliveira CA, Bou-Chacra NA, Robles Velasco MV, Baby AR · J Cosmet Dermatol (2020)

The development of photoprotective lipsticks containing natural bioactive compounds is a relevant current strategy to increase sun protection factor (SPF) value and lower the concentration of chemical UV filters, known for promoting sensitivity reactions. Twelve photoprotective lipsticks were developed by Design of Experiment (DOE) and characterized to verify the influence of Shea butter (Butyrospermum parkii), titanium dioxide (TiO 2 ), and ethylhexyl methoxycinnamate (EHM) on physical parameters and in vitro photoprotective efficacy. The influence of Shea butter, TiO 2, and EHM was evaluated by several parameters, such as melting point, colorimetry, thermal analysis by DSC, texture analysis, and sunscreen activity estimated in vitro. The construction of prediction models was possible for the following responses: maximum force by the cantilever test at 25 and 45&#xb0;C; maximum distance by hardness test at 25&#xb0;C; slope value at 25 and 45&#xb0;C by the cantilever test; and UVA/UVB ratio and in vitro SPF. TiO 2 and EHM contributed to changes on the in vitro SPF value; however, unexpectedly, Shea butter had no influence on this efficacy parameter. The assay allowed us to observe the influence of the variables in the analysis and to develop a response prediction model for some of the parameters assessed.

Contact allergy to Butyrospermum parkii butter in a patient with cheilitis [PMID: 38123238 · 2024]
Castelain F, Aubin F, Pelletier F · Contact Dermatitis (2024)
Fast non-aqueous reversed-phase liquid chromatography separation of triacylglycerol regioisomers with isocratic mobile phase. Application to different oils and fats [PMID: 28039812 · 2017]
Tamba Sompila AW, H&#xe9;ron S, Hmida D, Tchapla A · J Chromatogr B Analyt Technol Biomed Life Sci (2017)

The distribution of fatty acid species at the sn-1/3 position or the sn-2 position of triacylglycerols (TAGs) in natural fats and oils affects their physical and nutritional properties. In fats and oils, determining the presence of one or two regioisomers and the identification of structure, where they do have one, as well as their separation, became a problem of fundamental importance to solve. A variety of instrumental technics has been proposed, such as MS, chromatography-MS or pure chromatography. A number of studies deal with the optimization of the separation, but very often, they are expensive in time. In the present study, in order to decrease the analysis time while maintaining good chromatographic separation, we tested different monomeric and polymeric stationary phases and different chromatographic conditions (mobile phase composition and analysis temperature) using Non-Aqueous Reversed Phase Liquid Chromatography (NARP-LC). It was demonstrated that mixed polymeric stationary bonded silica with accessible terminal hydroxyl groups leads to very good separation for the pairs of TAGs regioisomers constituted by two saturated and one unsaturated fatty acid (with double bond number: from 1 to 6). A Nucleodur C18 ISIS percolated by isocratic mobile phase (acetonitrile/2-propanol) at 18&#xb0;C leads to their separations in less than 15min. The difference of retention times between two regioisomers XYX and XXY are large enough to confirm, as application, the presence of POP, SOP, SOS and PLP and no PPO, SPO, SSO and PPL in Theobroma cacao butter. In the same way, this study respectively shows the presence of SOS, SOP and no SSO, PSO in Butyrospermum parkii butter, POP, SOP, SOS and no PPO, PSO and SSO in Carapa oil and finally POP and no PPO in Pistacia Lentiscus oil.

常见问题解答 (FAQ)

Q1. BUTYROSPERMUM PARKII BUTTER 在全球 7 大法域的官方全成分标签名称是什么?
中国 NMPA《已使用化妆品原料目录 (IECIC)》标准中文名为 '未列入 IECIC 目录(严禁自行机器翻译)',美国 PCPC 与欧盟 CosIng 标准 INCI 为 'BUTYROSPERMUM PARKII (SHEA) BUTTER',日本 JCIA 表示名称为 'BUTYROSPERMUM PARKII BUTTER'。
Q2. BUTYROSPERMUM PARKII BUTTER 在中、韩、欧、美、日、东盟的法定监管状态 (Layer 1) 如何?
6 大法域监管汇总 — 中国(CN): none,韩国(KR): none,欧盟(EU): none,美国(US): none,日本(JP): none,东盟(ASEAN): none。
Q3. BUTYROSPERMUM PARKII BUTTER 的常规配方添加量 (Layer 3) 与最佳稳定 pH 窗口是多少?
在代表性剂型 (anhydrous_balm) 中常规添加量为 1%–23%(中位数 5%),最佳稳定 pH 范围为 4–8。
Q4. BUTYROSPERMUM PARKII BUTTER 有哪些配伍禁忌 (Incompatibilities) 与协同增效组合?
推荐协同组合包括 GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL;配伍禁忌注意:Verify phase compatibility under extreme pH or high electrolyte loads。